Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

InVivoMAb Anti-Nipah virus/NiV Glycoprotein G Antibody (SAA2192)

Catalog #:   VVV07904 Specific References (22) DATASHEET
Host species: Human
Isotype: IgG1
Applications: ELISA, Neutralization
Accession: Q9IH62
Overview

Catalog No.

VVV07904

Species reactivity

Nipah virus (NiV)

Host species

Human

Isotype

IgG1

Clonality

Monoclonal

Target

Glycoprotein G, G

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9IH62

Applications

ELISA, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA2192

Data Image
References

Design and Preliminary Immunogenicity Evaluation of Nipah Virus Glycoprotein G Epitope-Based Peptide Vaccine in Mice., PMID:40333318

A monoclonal antibody targeting the Nipah virus fusion glycoprotein apex imparts protection from disease., PMID:39240113

An in vivo BSL-2 model for henipavirus infection based on bioluminescence imaging of recombinant Cedar virus replication in mice., PMID:38770087

Computer-assisted identification of potential quinolone derivatives targeting Nipah virus glycoprotein attachment with human cell surface receptor ephrin-B2: Multistep virtual screening., PMID:37442011

Assessment of the immunogenicity and protection of a Nipah virus soluble G vaccine candidate in mice and pigs., PMID:36274696

Computational Identification of Potential Multitarget Inhibitors of Nipah Virus by Molecular Docking and Molecular Dynamics., PMID:35744699

Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates., PMID:34696372

Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy., PMID:32933033

Epitope-Based Peptide Vaccine against Glycoprotein G of Nipah Henipavirus Using Immunoinformatics Approaches., PMID:32377531

Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study., PMID:32027842

A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection., PMID:31686101

Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities., PMID:30866781

Generation of therapeutic antisera for emerging viral infections., PMID:30323953

Two highly similar LAEDDTNAQKT and LTDKIGTEI epitopes in G glycoprotein may be useful for effective epitope based vaccine design against pathogenic Henipavirus., PMID:26970211

Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection., PMID:25392218

Characterization of a third generation lentiviral vector pseudotyped with Nipah virus envelope proteins for endothelial cell transduction., PMID:23698741

Nipah virus envelope-pseudotyped lentiviruses efficiently target ephrinB2-positive stem cell populations in vitro and bypass the liver sink when administered in vivo., PMID:23192877

Nipah virus infection and glycoprotein targeting in endothelial cells., PMID:21054904

A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection., PMID:19888339

Ephrin-B2 expression critically influences Nipah virus infection independent of its cytoplasmic tail., PMID:19108727

Evidence of a potential receptor-binding site on the Nipah virus G protein (NiV-G): identification of globular head residues with a role in fusion promotion and their localization on an NiV-G structural model., PMID:16840334

Henipaviruses: recent observations on regulation of transcription and the nature of the cell receptor., PMID:15119767

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

InVivoMAb Anti-Nipah virus/NiV Glycoprotein G Antibody (SAA2192) [VVV07904]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only